Next Article in Journal
Behavioral Differences in the Preference for Hepatitis B Virus Vaccination: A Discrete Choice Experiment
Previous Article in Journal
Immune-Enhancing Activity of Aqueous Extracts from Artemisia rupestris L. via MAPK and NF-kB Pathways of TLR4/TLR2 Downstream in Dendritic Cells
Previous Article in Special Issue
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 8
Issue 3
10.3390/vaccines8030526
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection

by
Mark R. Schleiss
1,* and
Don J. Diamond
2,*
1
Department of Pediatrics, Medical School Campus, University of Minnesota, Minneapolis, MN 55455, USA
2
Department of Hematology/HCT, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA
*
Authors to whom correspondence should be addressed.
Vaccines 2020, 8(3), 526; https://doi.org/10.3390/vaccines8030526
Submission received: 9 September 2020 / Accepted: 10 September 2020 / Published: 14 September 2020
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...]

Share and Cite

MDPI and ACS Style

Schleiss, M.R.; Diamond, D.J. Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection. Vaccines 2020, 8, 526. https://doi.org/10.3390/vaccines8030526

AMA Style

Schleiss MR, Diamond DJ. Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection. Vaccines. 2020; 8(3):526. https://doi.org/10.3390/vaccines8030526

Chicago/Turabian Style

Schleiss, Mark R., and Don J. Diamond. 2020. "Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection" Vaccines 8, no. 3: 526. https://doi.org/10.3390/vaccines8030526

APA Style

Schleiss, M. R., & Diamond, D. J. (2020). Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection. Vaccines, 8(3), 526. https://doi.org/10.3390/vaccines8030526

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop